In addition, our findings revealed a correlation between the methylation levels of AIF-1 and dysfunctional T-cell phenotypes in the glioma, uveal, ovarian, head and neck cancer, DLBC, breast cancer, and endometrial cancer cohorts (Figure 9C). This evidence concerns the gene AIF1 and glioma.